title: Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF.
abstract: TLR4 activation by LPS (endotoxin) is mediated by the MyD88 and TRIF intracellular signaling pathways. We determined the relative activation of these pathways in murine ocular tissue after LPS exposure. Additionally, we explored whether BM-derived or non-BM-derived cells were the major contributors to EIU. Mice deficient in TRIF or MyD88 and their congenic (WT) controls received 250 ng ultrapure LPS ivt at 0 h. Ocular inflammation was assessed by histological analysis at 4, 6, and 24 h, and additionally, in MyD88(-/-) mice, intravital microscopy was performed at 4 h and 6 h to assess adherent, rolling, and infiltrating cells in the iris vasculature and tissue. Cytokines associated with the MyD88 and TRIF intracellular signaling pathways were analyzed in ocular tissue at 4 h. BM chimeric mice (WT→WT, TLR4(-/-)→WT, WT→TLR4(-/-)) received 250 ng LPS by ivt injection, and ocular tissues were examined by histology at 6 h. Lack of MyD88 resulted in a markedly diminished cellular response and reduced production of MyD88-related cytokines 4 h post-LPS treatment. In contrast, lack of TRIF led to reduced production of TRIF-related cytokines and no change in the cellular response to LPS. Therefore, the MyD88 pathway appears to be the dominant TLR4 pathway in EIU. Only WT → TLR4(-/-) chimeric mice were resistant to EIU, and this suggests, surprisingly, that non-BM-derived (radiation-resistant) cells in the eye play a greater role than BM-derived cells.
authors: Casey Eye Institute, Oregon Health and Science University, Portland, OR 97239, USA.
authors: J
authors: J
authors: Kezic
authors: S
authors: S
authors: Taylor
authors: S
authors: S
authors: Gupta
authors: S R
authors: SR
authors: Planck
authors: H L
authors: HL
authors: Rosenzweig
authors: J T
authors: JT
authors: Rosenbaum
references: Nat Rev Rheumatol. 2010 Dec;6(12):727-30
references: 20820197
references: Arthritis Rheum. 2002 Dec;46(12):3340-8
references: 12483741
references: Br J Ophthalmol. 2006 Jan;90(1):103-8
references: 16361678
references: J Immunol. 2007 Sep 15;179(6):4083-92
references: 17785847
references: Curr Opin Immunol. 2010 Feb;22(1):20-7
references: 20060278
references: J Leukoc Biol. 2008 Sep;84(3):721-9
references: 18577714
references: Mediators Inflamm. 2010;2010:748218
references: 20847811
references: Immunology. 2008 Dec;125(4):541-8
references: 18540963
references: J Exp Med. 1994 Dec 1;180(6):2359-64
references: 7964509
references: J Clin Invest. 2003 Apr;111(7):1011-20
references: 12671050
references: Am J Physiol Gastrointest Liver Physiol. 2010 Aug;299(2):G531-8
references: 20508155
references: Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):403-4
references: 16419427
references: Exp Eye Res. 2004 Aug;79(2):203-8
references: 15325567
references: J Immunol. 2009 Mar 1;182(5):2738-44
references: 19234168
references: Nat Med. 2010 Nov;16(11):1194-5
references: 21052069
references: J Leukoc Biol. 2008 Aug;84(2):529-36
references: 18495787
references: Mol Vis. 2009;15:619-28
references: 19347047
references: Arthritis Rheum. 2007 Sep;56(9):2957-67
references: 17763416
references: Nat Genet. 2001 Sep;29(1):19-20
references: 11528384
references: Exp Eye Res. 1995 Nov;61(5):629-32
references: 8654505
references: Nature. 1980 Aug 7;286(5773):611-3
references: 7402339
references: J Immunol Methods. 2000 Jun 23;240(1-2):23-37
references: 10854598
references: J Immunol. 2006 Dec 1;177(11):8103-10
references: 17114485
references: Nature. 2003 Aug 14;424(6950):743-8
references: 12872135
references: J Immunol. 2003 Sep 1;171(5):2652-9
references: 12928419
references: Invest Ophthalmol Vis Sci. 2002 May;43(5):1493-8
references: 11980865
references: Br J Ophthalmol. 1996 Apr;80(4):332-6
references: 8703885
references: Biochem Biophys Res Commun. 2005 Mar 11;328(2):383-92
references: 15694359
references: Ann Rheum Dis. 2010 Oct;69(10):1861-5
references: 20525845
references: Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1739-45
references: 19098321
references: Nature. 1997 Jul 24;388(6640):394-7
references: 9237759
references: J Immunol. 2009 Oct 15;183(8):5244-50
references: 19786543
references: Immunity. 2007 Nov;27(5):695-7
references: 18031693
references: Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1518-24
references: 18385071